Stryker stock reaches EUR 279.05, up 3.35% since prior report
Published on 10/29/2026 at 17:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat matters for investors now
- Stryker is scheduled to publish its third-quarter 2026 results after the U.S. market close on October 29.
- Analysts expect revenue of USD 6.62 billion and earnings of USD 3.55 per share for the quarter.
- The company operates in medical technology across Orthopaedics, MedSurg and Neurotechnology.
Stryker stock has moved higher since the previous report while investors await the company's third-quarter results. Stryker is scheduled to publish its Q3 2026 financial results after the U.S. market close on October 29, with a conference call scheduled for 4:30 p.m. Eastern time, according to StockTitan.
What has changed since the last report
At Lang & Schwarz, the stock was quoted at EUR 279.05 on October 29, 2026, at 17:00:31 Berlin time. The previous relevant report recorded EUR 270.00 on October 28, 2026, at 07:57 Berlin time. The difference is EUR 9.05, or 3.35 percent, calculated from the earlier quote. This comparison is separate from a Xetra daily performance figure; no dated Xetra closing basis is included here.
The fresh quote is the relevant new market information in this second report. It does not by itself establish why the price changed or predict the direction of the forthcoming earnings response.
The earnings hurdle
MarketBeat lists consensus expectations of USD 6.62 billion in revenue and USD 3.55 in earnings per share for Q3 2026. The same source says Stryker reported USD 6.59 billion in revenue and USD 3.69 in earnings per share for the second quarter, when it exceeded the consensus EPS estimate. The upcoming release will therefore give investors a new comparison with both the prior quarter and current expectations.
Business and investor context
Stryker is a U.S. medical technology company serving healthcare providers. Its portfolio covers Orthopaedics, MedSurg and Neurotechnology, while the company profile identifies Healthcare as its sector and Medical - Devices as its industry. Investors should focus on the reported revenue trend, earnings delivery and management commentary rather than treating the pre-release quote as a forecast.
For a real-time quote of Stryker Corp stock, investors can follow the instrument separately from the U.S. listing.
Broader sentiment for U.S. equities can be followed through the S&P 500 market environment.
More news and analyses are available on Stryker Corp stock.
Stryker Corporation at a glance
- ISIN: US8636671013
- Ticker: SYK
- Exchange: NYSE
- Sector: Healthcare
- Industry: Medical - Devices
- Lang & Schwarz quote: EUR 279.05 on October 29, 2026, at 17:00:31 Berlin time
- Change since the October 28 report: +3.35 percent from EUR 270.00
